Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cliniphar's average Accounts Payable for the
six
months ended in Mar. 2026 was 円18 Mil. Cliniphar's Cost of Goods Sold for the
six
months ended in Mar. 2026 was 円3,057 Mil.
Hence, Cliniphar's Days Payable for the
six
months ended in Mar. 2026 was 1.05.
The historical rank and industry rank for Cliniphar's Days Payable or its related term are showing as below:
TSE:432A'
s Days Payable Range Over the Past 10 Years
Min: 1.51 Med: 1.75 Max: 2.1
Current: 2.1
During the past 3 years, Cliniphar's highest Days Payable was 2.10. The lowest was 1.51. And the median was 1.75.
TSE:432A's Days Payable is not ranked
in the Healthcare Providers & Services industry.
Industry Median: 57.13
vs TSE:432A: 2.10
Cliniphar's Days Payable
increased
from Mar. 2024 (1.51) to Mar. 2026 (2.10).
It may suggest that Cliniphardelayed paying its suppliers.
Cliniphar Days Payable Related Terms
Cliniphar Days Payable Historical Data
* Premium members only.
The historical data trend for Cliniphar's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cliniphar Days Payable Chart
Cliniphar Annual Data
Trend
Mar24
Mar25
Mar26
Days Payable
1.51
1.75
2.10
Cliniphar Semi-Annual Data
Mar24
Mar25
Mar26
Days Payable
1.51
1.75
2.10
Cliniphar Days Payable Competitor Comparison
For the Pharmaceutical Retailers subindustry, Cliniphar's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cliniphar Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cliniphar's Days Payable distribution charts can be found below:
* The bar in red indicates where Cliniphar's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Cliniphar's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cliniphar (TSE:432A) has a Days Payable of 2.10 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Cliniphar and its competitors. This is 20% above median its historical median of 1.75. Over the past decade, Cliniphar's Days Payable has ranged from 1.51 to 2.10.
Is Cliniphar's Days Payable too high?
Cliniphar's current Days Payable of 2.10 is 20% above median its 10-year median of 1.75. Over the past 10 years, this metric has ranged from a low of 1.51 to a high of 2.10. The Healthcare Providers & Services industry median Days Payable is 57.13. Cliniphar's value of 2.10 is 96.3% below this industry median. Overall, Cliniphar has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Cliniphar's Days Payable compare to competitors?
Cliniphar's Days Payable of 2.10 can be compared against companies in the Healthcare Providers & Services industry. The industry median Days Payable is 57.13. Cliniphar's value of 2.10 is 96.3% below this benchmark. Historically, Cliniphar's own Days Payable has ranged from 1.51 to 2.10 over the past decade. While the company's 10-year median is 1.75 vs. the industry median of 57.13, Cliniphar has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 57.13, based on 607 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cliniphar's current Days Payable of 2.10 is 96.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Cliniphar and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 57.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cliniphar's current Days Payable is 2.10, which is 20% above median its own 10-year median of 1.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cliniphar stock overvalued right now?
Cliniphar (TSE:432A) has a current Days Payable of 2.10. The current Days Payable is 2.10, which is 20% above median its 10-year median of 1.75 and 96.3% below the Healthcare Providers & Services industry median of 57.13. Cliniphar's overall GF Score™ is 20/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Cliniphar (TSE:432A), the current Days Payable is 2.10 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:432A has been successfully added to your 
